PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cathepsin G 1,613 Target Disease Dementia 66,782 1 0.00 -1.00 0.00 0.50
Cathepsin G 1,613 Target Target EGF 27,487 1 0.00 -1.00 0.00 0.52
Cathepsin G 1,613 Target Target Platelet Activating Factor 9,915 15 0.00 -0.99 0.01 0.63
Cathepsin G 1,613 Target Target Toll-Like Receptor 2 2,174 1 0.00 -1.00 0.00 0.59
Cathepsin G 1,613 Target Target Alpha-1 AntiChymotrypsin 1,460 75 0.05 -0.95 0.05 0.78
Cathepsin G 1,613 Target Target D-Dimer 6,185 3 0.00 -1.00 0.00 0.59
Cathepsin G 1,613 Target Disease Muscle Relaxation 4,706 1 0.00 -1.00 0.00 0.57
Cathepsin G 1,613 Target Target CCL2 3,560 2 0.00 -1.00 0.00 0.60
Cathepsin G 1,613 Target Disease Respiratory Tract Infections 9,721 1 0.00 -1.00 0.00 0.55
Cathepsin G 1,613 Target Disease Cryoglobulinemia 2,693 1 0.00 -1.00 0.00 0.58
Cathepsin G 1,613 Target Disease Lung Carcinoma 13,423 3 0.00 -1.00 0.00 0.57
Cathepsin G 1,613 Target Disease Multiple Myeloma 24,594 3 0.00 -1.00 0.00 0.55
Cathepsin G 1,613 Target Disease Stroke 146,992 5 0.00 -1.00 0.00 0.52
Cathepsin G 1,613 Target Target Eotaxin 2,457 2 0.00 -1.00 0.00 0.61
AACT 109 Target Disease Anxiety Disorder 8,985 1 0.00 -1.00 0.01 0.60
AACT 109 Target Target BCHE 1,167 2 0.01 -0.99 0.02 0.68
AACT 109 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.01 0.54
AACT 109 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.01 0.56
AACT 109 Target Disease Inflammation 252,734 2 0.00 -0.99 0.02 0.54
AACT 109 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.55
AACT 109 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
AACT 109 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
AACT 109 Target Disease Leukemia 162,805 2 0.00 -0.99 0.02 0.55
AACT 109 Target Disease Pain 409,851 2 0.00 -0.99 0.02 0.53
AACT 109 Target Disease Sepsis 64,798 1 0.00 -1.00 0.01 0.55
AACT 109 Target Disease Dementia 66,782 3 0.00 -0.99 0.03 0.58
Cathepsin G 1,613 Target Target CCL5 2,002 1 0.00 -1.00 0.00 0.59
Cathepsin G 1,613 Target Disease Glomerulonephritis 23,459 17 0.00 -0.99 0.01 0.60
Cathepsin G 1,613 Target Disease Basal Cell Carcinoma 7,953 1 0.00 -1.00 0.00 0.55
Cathepsin G 1,613 Target Target ERK1 18,374 1 0.00 -1.00 0.00 0.53
Cathepsin G 1,613 Target Target Annexin A1 406 1 0.00 -1.00 0.00 0.63
Cathepsin G 1,613 Target Target Adenosine Deaminase 6,613 1 0.00 -1.00 0.00 0.56
Cathepsin G 1,613 Target Target Tissue-Type Plasminogen Activator 5,020 9 0.00 -1.00 0.01 0.64
Cathepsin G 1,613 Target Disease Benign Prostatic Hyperplasia 10,026 1 0.00 -1.00 0.00 0.54
Cathepsin G 1,613 Target Disease Anemia 81,663 2 0.00 -1.00 0.00 0.51
Cathepsin G 1,613 Target Disease Diabetic Nephropathy 12,496 1 0.00 -1.00 0.00 0.54
Cathepsin G 1,613 Target Disease Arthritis 128,324 55 0.00 -0.98 0.03 0.59
Cathepsin G 1,613 Target Target Xanthine Oxidase 8,860 8 0.00 -1.00 0.00 0.61
Cathepsin G 1,613 Target Disease Headache 50,687 1 0.00 -1.00 0.00 0.50
Cathepsin G 1,613 Target Disease Renal Failure 73,993 1 0.00 -1.00 0.00 0.50
Cathepsin G 1,613 Target Disease Pneumonia 81,521 10 0.00 -1.00 0.01 0.55
Cathepsin G 1,613 Target Disease Cerebral Edema 3,889 1 0.00 -1.00 0.00 0.57
Cathepsin G 1,613 Target Disease Shock 134,031 16 0.00 -0.99 0.01 0.55
Cathepsin G 1,613 Target Target Phospholipase A2 13,400 5 0.00 -1.00 0.00 0.58
Cathepsin G 1,613 Target Disease Drug Hypersensitivity 902 1 0.00 -1.00 0.00 0.61
Cathepsin G 1,613 Target Target EDF 379 1 0.00 -1.00 0.00 0.63
Cathepsin G 1,613 Target Disease Influenza 67,933 2 0.00 -1.00 0.00 0.51
Cathepsin G 1,613 Target Target AFP 9,751 1 0.00 -1.00 0.00 0.55
Cathepsin G 1,613 Target Target A1AT 329 2 0.00 -1.00 0.01 0.65
Cathepsin G 1,613 Target Disease Bacterial Infections 14,248 3 0.00 -1.00 0.00 0.57
Cathepsin G 1,613 Target Disease Proteinuria 28,803 3 0.00 -1.00 0.00 0.55
Cathepsin G 1,613 Target Disease Lung Cancer 91,416 4 0.00 -1.00 0.00 0.52
Aldosterone Receptor 528 Target Disease Tachyarrhythmia 2,584 2 0.00 -1.00 0.00 0.63
Aldosterone Receptor 528 Target Drug Apresoline (Hydralazine)- FDA 20 2 0.02 -0.95 0.10 0.73
Aldosterone Receptor 528 Target Disease Nephrotic Syndrome 14,681 1 0.00 -1.00 0.00 0.56
Aldosterone Receptor 528 Target Disease Proteinuria 28,803 32 0.01 -0.97 0.06 0.64
Aldosterone Receptor 528 Target Disease Hyperlipidemia 15,317 1 0.00 -1.00 0.00 0.56
Aldosterone Receptor 528 Target Disease Muscle Weakness 9,178 1 0.00 -1.00 0.00 0.57
Aldosterone Receptor 528 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.00 0.50
Aldosterone Receptor 528 Target Disease Pain 409,851 2 0.00 -1.00 0.00 0.50
Aldosterone Receptor 528 Target Drug Drospirenone 514 11 0.02 -0.98 0.02 0.76
Aldosterone Receptor 528 Target Target Renin 43,456 147 0.03 -0.85 0.28 0.68
Aldosterone Receptor 528 Target Disease Dyslipidemia 15,225 1 0.00 -1.00 0.00 0.56
Aldosterone Receptor 528 Target Disease Cardiac Arrest 20,700 2 0.00 -1.00 0.00 0.57
Aldosterone Receptor 528 Target Target Angiotensin-Converting Enzyme 2 665 1 0.00 -1.00 0.00 0.65
Aldosterone Receptor 528 Target Disease Menopause 19,680 3 0.00 -1.00 0.01 0.58
Aldosterone Receptor 528 Target Target Collagen 138,882 49 0.01 -0.95 0.09 0.60
Aldosterone Receptor 528 Target Disease Cholesterol 182,390 6 0.00 -0.99 0.01 0.54
Aldosterone Receptor 528 Target Disease Hypocalcemia 6,174 1 0.00 -1.00 0.00 0.58
Aldosterone Receptor 528 Target Disease Inflammation 252,734 30 0.00 -0.97 0.06 0.57
Aldosterone Receptor 528 Target Disease Heart Disease 118,291 13 0.00 -0.99 0.02 0.57
Aldosterone Receptor 528 Target Disease Contraception 21,402 3 0.00 -1.00 0.01 0.58
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Target Collagen 138,882 1 0.00 -0.87 0.25 0.59
Eotaxin 2,457 Target Disease Drug Hypersensitivity 902 2 0.00 -1.00 0.00 0.62
Eotaxin 2,457 Target Disease Influenza 67,933 19 0.00 -1.00 0.01 0.56
Eotaxin 2,457 Target Target Adiponectin 11,994 14 0.00 -1.00 0.01 0.61
Eotaxin 2,457 Target Target AFP 9,751 2 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Target ERK1 18,374 27 0.00 -0.99 0.01 0.62
Eotaxin 2,457 Target Disease Osteoporosis 46,215 2 0.00 -1.00 0.00 0.51
Eotaxin 2,457 Target Target ANGPTL4 289 1 0.00 -1.00 0.00 0.62
Eotaxin 2,457 Target Target CCL5 2,002 58 0.03 -0.97 0.03 0.74
Aldosterone Receptor 528 Target Disease Acute Coronary Syndromes 9,133 1 0.00 -1.00 0.00 0.57
Eotaxin 2,457 Target Disease Gastroesophageal Reflux Disease 7,437 14 0.00 -1.00 0.01 0.63
Eotaxin 2,457 Target Disease Multiple Myeloma 24,594 3 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Smallpox 6,258 1 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target Adp-Ribosylation Factor 1 196 1 0.00 -1.00 0.01 0.63
Eotaxin 2,457 Target Disease Aspergillosis 9,759 4 0.00 -1.00 0.00 0.58
Eotaxin 2,457 Target Disease Dyspnea 24,781 1 0.00 -1.00 0.00 0.51
Eotaxin 2,457 Target Disease Stroke 146,992 2 0.00 -1.00 0.00 0.49
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Disease Inflammation 252,734 1 0.00 -0.87 0.25 0.58
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Disease Leukemia 162,805 4 0.00 -0.45 1.00 0.62
Eotaxin 2,457 Target Disease Lung Carcinoma 13,423 1 0.00 -1.00 0.00 0.53
Aldosterone Receptor 528 Target Disease Respiratory Tract Infections 9,721 1 0.00 -1.00 0.00 0.57
Aldosterone Receptor 528 Target Disease Hypotension 42,123 1 0.00 -1.00 0.00 0.53
Aldosterone Receptor 528 Target Disease Gout 8,355 1 0.00 -1.00 0.00 0.57
DC-CK1 22 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -0.95 0.09 0.59
DC-CK1 22 Target Target CCL2 3,560 1 0.00 -0.98 0.05 0.65
DC-CK1 22 Target Disease Arthritis 128,324 2 0.00 -0.95 0.09 0.58
DC-CK1 22 Target Target CCL5 2,002 1 0.00 -0.98 0.05 0.67
DC-CK1 22 Target Target Eotaxin 2,457 1 0.00 -0.98 0.05 0.66